Coherus BioSciences, Inc. (NASDAQ:CHRS) Q2 2023 Earnings Call Transcript August 2, 2023
Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $0.52.
Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Second Quarter 2023 Conference Call. At this time all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be...
